| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |